80.7300 -5.42 (-6.29%)
NSE May 06, 2025 15:31 PM
Volume: 2.5M
 

ICICI Securities Limited
Niva Bupa has been able to deliver standout growth in health insurance premiums (~40% CAGR between FY20-25) while its improved scale and assets under management should help improve margins and earnings growth ahead (expect IFRS PAT CAGR of 53% over FY25-27E).
Motilal Oswal released a Buy report for Niva Bupa Health Insurance Company Ltd. with a price target of 100.0 on 23 Apr, 2025.
More from Niva Bupa Health …
All earning calls
Investor presentations from Niva Bupa Health …
All investor presentations